AASDHPPT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.733820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.371000E-01
Normal-vs-Stage2
1.394990E-01
Normal-vs-Stage3
1.021740E-03
Normal-vs-Stage4
3.697600E-01
Stage1-vs-Stage2
5.141000E-01
Stage1-vs-Stage3
5.190500E-02
Stage1-vs-Stage4
8.973200E-01
Stage2-vs-Stage3
2.944700E-03
Stage2-vs-Stage4
7.149000E-01
Stage3-vs-Stage4
1.735210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.790240E-01
Normal-vs-AfricanAmerican
4.214400E-01
Normal-vs-Asian
5.015800E-02
Caucasian-vs-AfricanAmerican
3.878000E-01
Caucasian-vs-Asian
1.663200E-01
AfricanAmerican-vs-Asian
9.782400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.155650E-01
Normal-vs-Female
2.697800E-01
Male-vs-Female
2.553000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.181800E-02
Normal-vs-Age(41-60Yrs)
4.436600E-01
Normal-vs-Age(61-80Yrs)
1.099800E-01
Normal-vs-Age(81-100Yrs)
2.971700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.217600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.195200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.163600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.783500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.373600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.758230E-01
Normal-vs-Daily Drinker
6.408200E-02
Normal-vs-Weekly Drinker
7.275300E-03
Normal-vs-Occasional Drinker
5.246000E-01
Normal-vs-Social Drinker
2.867600E-01
Non Drinker-vs-Daily Drinker
7.811200E-01
Non Drinker-vs-Weekly Drinker
2.709800E-01
Non Drinker-vs-Occasional Drinker
1.735360E-01
Non Drinker-vs-Social Drinker
4.271600E-01
Daily Drinker-vs-Weekly Drinker
3.054800E-01
Daily Drinker-vs-Occasional Drinker
9.216400E-02
Daily Drinker-vs-Social Drinker
2.516800E-01
Weekly Drinker-vs-Occasional Drinker
2.300200E-02
Weekly Drinker-vs-Social Drinker
5.198300E-02
Occasional Drinker-vs-Social Drinker
6.049400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.997600E-02
Normal-vs-Grade 2
2.154200E-02
Normal-vs-Grade 3
6.762400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.291600E-01
Grade 1-vs-Grade 3
9.540200E-01
Grade 1-vs-Grade 4
6.997600E-02
Grade 2-vs-Grade 3
1.326020E-01
Grade 2-vs-Grade 4
2.154200E-02
Grade 3-vs-Grade 4
6.762400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.718500E-02
Normal-vs-NonDiabetic
1.510160E-01
Diabetic-vs-NonDiabetic
3.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.640490E-03
Normal-vs-NoPancreatitis
1.519250E-01
Pancreatitis-vs-NoPancreatitis
1.083810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.223200E-01
Normal-vs-N1
1.615560E-01
N0-vs-N1
7.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.031000E-01
Normal-vs-TP53-NonMutant
3.872800E-01
TP53-Mutant-vs-TP53-NonMutant
8.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
